A 6-year-old girl presents with low-grade fever, mild malaise, and bilateral parotid swelling for 3 days. Her mother reports no vaccination history. Which single laboratory or clinical finding would best distinguish mumps from rubella?

## Distinguishing Mumps from Rubella: Best Single Discriminating Finding **Key Point:** The question asks for the **single best** laboratory **or** clinical finding to distinguish mumps from rubella. While parotitis is the hallmark of mumps, the presence of **IgM antibodies to mumps virus** is the definitive, unambiguous discriminator — it is both disease-specific and directly rules out rubella. ### Why Option A is Correct The stem explicitly asks for a "single laboratory **or** clinical finding" that **best distinguishes** mumps from rubella. IgM antibodies to mumps virus: - Are **specific** to acute mumps infection (appear within days of symptom onset) - Are **absent** in rubella (which would show IgM to rubella virus instead) - Provide a **definitive** diagnosis, unlike clinical features that can overlap Per **Harrison's Principles of Internal Medicine**, serological confirmation of mumps via mumps-specific IgM is the gold standard for acute diagnosis, particularly in partially vaccinated or unvaccinated populations. ### Why Option B is Incorrect as the "Best" Answer Option B states "Absence of lymphadenopathy; parotitis is the dominant feature in mumps." While parotitis does distinguish mumps clinically, this option is problematic: - The phrasing relies on a **double negative** ("absence of lymphadenopathy"), making it logically harder to apply - Lymphadenopathy can occur in mumps (submandibular region), so "absence" is not absolute - Clinical overlap between parotitis and other causes (e.g., bacterial parotitis, EBV) means parotitis alone is not as definitive as serology - The stem asks for the **best** discriminator — serology is superior to clinical signs for definitive distinction ### Clinical Comparison: Mumps vs. Rubella | Feature | Mumps | Rubella | | --- | --- | --- | | **Primary manifestation** | Bilateral parotid swelling (parotitis) | Fine maculopapular rash | | **Rash** | Absent | Present; face → trunk | | **Lymphadenopathy** | Minimal | Prominent (posterior cervical, occipital) | | **Serology** | IgM anti-mumps positive | IgM anti-rubella positive | | **Salivary gland involvement** | Yes (parotitis) | No | | **Complications** | Orchitis, meningitis, pancreatitis | Congenital rubella syndrome | **High-Yield:** - **Best clinical discriminator**: Parotitis (mumps) vs. Rash + lymphadenopathy (rubella) - **Best laboratory discriminator**: Mumps-specific IgM antibodies — definitive and disease-specific **Clinical Pearl:** Per Park's Textbook of Preventive and Social Medicine, mumps IgM serology is the recommended confirmatory test in outbreak settings. A positive mumps IgM in a child with parotitis conclusively distinguishes mumps from rubella, which would instead show rubella-specific IgM. When the stem offers both laboratory and clinical options and asks for the "best" single finding, the laboratory test with highest specificity takes precedence.